메뉴 건너뛰기
Nature Clinical Practice Gastroenterology and Hepatology
Volumn 3, Issue 4, 2006, Pages 196-197
How effective is fluoxetine for the treatment of pain and constipation-predominant irritable bowel syndrome? Commentary
Author keywords

Constipation predominant irritable bowel syndrome; Fluoxetine; Pain; Selective serotonin reuptake inhibitors
Indexed keywords

FLUOXETINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;
EID: 33645645187     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0444     Document Type: Short Survey
Times cited : (2)
References (6)
  • 1
    • 0028301413 scopus 로고
    • Influence of antidepressants on whole gut orocaecal transit times in health and irritable bowel syndrome
    • Gorard DA et al. (1994) Influence of antidepressants on whole gut orocaecal transit times in health and irritable bowel syndrome. Aliment Pharmacol Ther 8: 159-166
    • (1994) Aliment Pharmacol Ther , vol.8 , pp. 159-166
    • Gorard, D.A.1
  • 2
    • 0141892613 scopus 로고    scopus 로고
    • Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans
    • Chial HJ et al. (2003) Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. Clin Gastroenterol Hepatol 1: 211-218
    • (2003) Clin Gastroenterol Hepatol , vol.1 , pp. 211-218
    • Chial, H.J.1
  • 3
    • 2942525747 scopus 로고    scopus 로고
    • Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome
    • Coates MD et al. (2004) Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126: 1657-1664
    • (2004) Gastroenterology , vol.126 , pp. 1657-1664
    • Coates, M.D.1
  • 4
    • 0037309719 scopus 로고    scopus 로고
    • The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome
    • Creed F et al. (2003) The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 124: 303-317
    • (2003) Gastroenterology , vol.124 , pp. 303-317
    • Creed, F.1
  • 5
    • 0038418617 scopus 로고    scopus 로고
    • The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: A double blind, randomized, placebo-controlled study
    • Kuiken SD et al. (2003) The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: A double blind, randomized, placebo-controlled study. Clin Gastoenterol Hepatol 1: 219-228
    • (2003) Clin Gastoenterol Hepatol , vol.1 , pp. 219-228
    • Kuiken, S.D.1
  • 6
    • 20944442466 scopus 로고    scopus 로고
    • Selective serotonin re-uptake inhibitors and the risk of bleeding
    • Weinrieb RM et al. (2005) Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opin Drug Saf 4: 337-344
    • (2005) Expert Opin Drug Saf , vol.4 , pp. 337-344
    • Weinrieb, R.M.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.